Skip to main content
. 2013 Jun 13;15(3):893–896. doi: 10.1208/s12248-013-9497-z

Table V.

Association with Posttreatment ADA Induction at Product Level

Association with ADA induction No association with ADA induction
Products with Pre-Ab 67% (4/6a) 33% (2/6)
Products without Pre-Ab 60% (3/5) 40% (2/5)
Products with Pre-Ab and studied in RA 100% (3/3) 0% (0/3)

aOne of the seven products associated with pre-existing antibodies (Pre-Ab) was excluded from comparison with posttreatment ADA induction, as the pre-Ab was only observed in placebo group